Business & Market News

Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries. from US Top News and Analysis https://ift.tt/eHjzdaq https://ift.tt/o9RiuHV

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading. from US Top News and Analysis https://ift.tt/GxUdifC https://ift.tt/cpZbV6D

We're raising our price target on the industrial conglomerate, which makes everything from gas pumps to data center components. from US Top News and Analysis https://ift.tt/52ehPkC https://ift.tt/eWz1GwA

Instead of focusing on those numbers, investors are spooked by signs of a softening property insurance market, with competition increasing and rates declining. from US Top News and Analysis https://ift.tt/Uy8kdJC https://ift.tt/7v89pAF

The confirmation hearing for President Trump's nominee to be the next Fed chairman once again sparked heated debate. from US Top News and Analysis https://ift.tt/PO1V0CH https://ift.tt/yJjqQn5

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading. from US Top News and Analysis https://ift.tt/0jwWyxY https://ift.tt/IkTKmzt